BIOMARKER:

STAG2 mutation

Entrez ID:

Related biomarkers:

‹

›

STAG2 mutation STAG2 mutation	Acute Myelogenous Leukemia AML	STAG2 mutation STAG2 mutation	Acute Myelogenous Leukemia AML	talazoparib Sensitive: C2 – Inclusion Criteria	talazoparib Sensitive: C2 – Inclusion Criteria
STAG2 mutation STAG2 mutation	Acute Myelogenous Leukemia AML	STAG2 mutation STAG2 mutation	Acute Myelogenous Leukemia AML	cytarabine/daunorubicin liposomal formulation Sensitive: C3 – Early Trials	cytarabine / daunorubicin liposomal formulation Sensitive: C3 – Early Trials
STAG2 mutation STAG2 mutation	Acute Myelogenous Leukemia AML	STAG2 mutation STAG2 mutation	Acute Myelogenous Leukemia AML	LY3009120 Resistant: C3 – Early Trials	LY3009120 Resistant: C3 – Early Trials
STAG2 mutation STAG2 mutation	Colorectal Cancer CRC	STAG2 mutation STAG2 mutation	Colorectal Cancer CRC	sintilimab + fruquintinib Resistant: C3 – Early Trials	sintilimab + fruquintinib Resistant: C3 – Early Trials
STAG2 mutation STAG2 mutation	Glioblastoma GBM	STAG2 mutation STAG2 mutation	Glioblastoma GBM	olaparib Sensitive: D – Preclinical	olaparib Sensitive: D – Preclinical